UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International Travellers

UK has added India's indigenously-made Covaxin to its list of approved Coronavirus vaccines for international travellers.

The move will benefit more fully vaccinated Indians planning travel to the UK without the need for a pre-departure PCR test or self-isolation at the address declared on their compulsory Passenger Locator Forms, reports NewsOnAIR.

Covaxin, which is developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is the seventh Covid-19 jab that has been approved for International travellers in the UK. Earlier, the UK government had approved vaccines from Oxford/AstraZeneca, Pfizer-BioNTech, Moderna, J&J, Sinovac and Sinopharm for the international travellers.

Earlier the, the Bharat Biotech manufactured Covaxin had received its WHO emergency use listing status, resulting in the UK announcing plans to include it on its list of approved COVID vaccines from 22 November.

The WHO Emergency Use Listing process includes a review of the quality, safety and efficacy data performed by WHO experts, and many countries such as the United States, Spain, Sweden, Switzerland and Iceland recognise this categorisation.